TO THE EDITOR: I have read with interest the commentary by Pillarsetty et al.(1) in the
December issue. Although the idea of investigating nuclear medicine-based solutions for …

TO THE EDITOR: As every medical department worldwide is bracing for the impact the
coronavirus disease 2019 (COVID-19) pandemic will pose on daily routines, the scientific …

TO THE EDITOR: We read with great interest the recent publication entitled ''Dr. Li Wenliang
and the Time of COVID-19''(1). As mentioned in this article, Dr. Li was reprimanded initially …

In an article in the December 21 issue of Pharmaceutics, Neumaier et al. from the Institute of
Neuroscience (Jülich), University Hospital Cologne/University of Cologne, and the Max …

CR3022 is a human antibody that binds to severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2). Here, we explore the use of CR3022 as a molecularly targeted …

TO THE EDITOR: Sometimes we need to challenge the views of colleagues and friends,
especially when their thinking has the effect of muddying the waters rather than providing …

We read with great interest the recent editorial by Huang et al.[1] regarding the unfortunately
timely topic of considerations attendant to running a nuclear medicine department in the …

TO THE EDITOR: Several recent studies relate to the use of PET/CT to assess pulmonary
inflammation and precautions in general when COVID-19 patients are in need of nuclear …

The American Board of Nuclear Medicine (ABNM) recognizes the strains under which
diplomates are currently practicing and wants them to prioritize their time to serve the …

The emergence and global spread of COVID-19, an infectious disease caused by the novel
coronavirus SARS-CoV-2, has resulted in a continuing pandemic threat to global health …